Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio

333-250036) (as amended, the Registration Statement), relating to the previously announced business combination (the Business Combination) with Nuvation Bio Inc. (Nuvation Bio), has been declared effective by the U.S. Securities and Exchange Commission (SEC) and that it has commenced mailing the definitive proxy statement/prospectus relating to the Special Meeting (the Special Meeting) of the Companys stockholders to be held on February 9, 2021 in connection with the Business Combination.